Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F K Jansen

Showing results (41-50 of 46) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 46 results.
International Journal of Cancer|October 15, 1982
Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97P Casellas, J P Brown, O Gros, et al.
Behring Institute Mitteilungen|May 1, 1984
Present potential of immunotoxinsP Poncelet, H E Blythman, D Carriere, et al.
Presse Medicale (Paris, France : 1983)|November 2, 1985
[Autograft of bone marrow treated by immunotoxin T 101 for the treatment of T-cell leukemia and lymphoma. Initial clinical cases]N C Gorin, L Douay, J P Laporte, et al.
Cancer Research|January 1, 1985
Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantationL Douay, N C Gorin, M Lopez, et al.
Immunological Reviews|January 1, 1982
Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicityF K Jansen, H E Blythman, D Carrière, et al.
Bulletin Du Cancer|January 1, 1983
[Immunotoxins]F K Jansen, H E Blythman, D Carrière, et al.
Pageof 5

Showing results (41-50 of 46) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 46 results.
International Journal of Cancer|October 15, 1982
Human melanoma cells can be killed in vitro by an immunotoxin specific for melanoma-associated antigen p97P Casellas, J P Brown, O Gros, et al.
Behring Institute Mitteilungen|May 1, 1984
Present potential of immunotoxinsP Poncelet, H E Blythman, D Carriere, et al.
Presse Medicale (Paris, France : 1983)|November 2, 1985
[Autograft of bone marrow treated by immunotoxin T 101 for the treatment of T-cell leukemia and lymphoma. Initial clinical cases]N C Gorin, L Douay, J P Laporte, et al.
Cancer Research|January 1, 1985
Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantationL Douay, N C Gorin, M Lopez, et al.
Immunological Reviews|January 1, 1982
Immunotoxins: hybrid molecules combining high specificity and potent cytotoxicityF K Jansen, H E Blythman, D Carrière, et al.
Bulletin Du Cancer|January 1, 1983
[Immunotoxins]F K Jansen, H E Blythman, D Carrière, et al.
Pageof 5